Skip to content
PodcastsScienceFrankly Speaking About Family Medicine

Frankly Speaking About Family Medicine

Pri-Med
Frankly Speaking About Family Medicine
Latest episode

503 episodes

  • Frankly Speaking About Family Medicine

    PMOS—Expanding Diagnosis and Care Beyond Cysts and Cycles - Frankly Speaking Ep 505

    2026/10/05 | 12 mins.
    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-505

    Overview: The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) reflects the true complexity of this diagnosis—a condition that extends beyond ovarian cysts and reproductive health. Listen in as we explore what drove the name change, how it better reflects the condition’s complexity, and what current evidence says about prevalence, risk, and whole-body management strategies for your patients.

    Episode resource links:

    Teede, H. J., Khomami, M. B., Morman, R., Laven, J. S., Joham, A. E., Costello, M. F., ... & Piltonen, T. (2026). Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet.

     

    Tewari, S., Khalua, R. K., & Parida, S. (2026). Redefining polycystic ovary syndrome (PCOS) as Polyendocrine Metabolic Ovarian Syndrome (PMOS): implications for diagnosis, pathophysiology and clinical management. Int J Gynaecol Sci, 8(1), 17-25.

     

    Tewari, S., Pramanik, P., Patra, T., & MK, M. (2026). From Reproductive Disorder to Metabolic Syndrome: The Evolution of Polycystic Ovary Syndrome (PCOS) into Polyendocrine Metabolic Ovarian Syndrome (PMOS). Journal of Pharmacognosy and Phytochemistry, 15(3), 329-337.

    Guest: Mariyan L. Montaque, DNP, FNP-BC
     
    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

    The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
  • Frankly Speaking About Family Medicine

    Lowering the Pressure: Hypertension Guidelines Interpreted - Frankly Speaking Ep 504

    2026/09/28 | 14 mins.
    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-504

    Overview: In this episode, we discuss the American College of Cardiology (ACC)/American Heart Association (AHA) hypertension guidelines, explore where the evidence may support or challenge recommendations, and provide practical frameworks for implementing lifestyle interventions to improve the outcomes of hypertension care.

    Episode resource links:

    Guest: Robert A. Baldor MD, FAAFP

    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

    The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
  • Frankly Speaking About Family Medicine

    The Nutrition Prescription: Can Legumes and Soy Lower Hypertension Risk? - Frankly Speaking Ep 503

    2026/09/21 | 13 mins.
    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-503

    Overview: In this episode, we discuss how prescribing “food as medicine” can complement hypertension management in primary care. We review the evidence supporting legumes, soy, and DASH-based nutrition for lowering blood pressure, while providing practical counseling strategies to help patients adopt dietary patterns that enhance cardiovascular health alongside standard medical therapy.

    Episode resource links:

    Metoudi M, et al. bmjnph 2026;0:e001449. doi:10.1136/bmjnph-2025-001449

    Brindal E, Baird D. Regular Flatulence Patterns Among Community-Dwelling Individuals in Australia. JAMA Netw Open. 2026;9(5):e2615637. doi:10.1001/jamanetworkopen.2026.15637

    DASH - DASH Eating Plan | NHLBI, NIH

    Guest: Robert A. Baldor MD, FAAFP

    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

    The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
  • Frankly Speaking About Family Medicine

    Abdominal Obesity and Menopausal Symptoms: Recognizing the Connection, Personalizing Care - Frankly Speaking Ep 502

    2026/09/14 | 17 mins.
    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-502

    Overview: Abdominal obesity can influence both the severity of menopausal symptoms and treatment decisions. Listen in as we discuss how to recognize this important relationship, apply practical screening tools, and individualize menopause management to improve symptom control and overall health outcomes for your patients.

    Episode resource links:

    Wang, D. , Wang, F. , Zheng, J. , Chen, X. , Lei, Y. & Su, J.  (9900).  Menopausal symptom network differences between women with and without waist-to-height ratio-defined abdominal obesity.  Menopause,  Publish Ahead of Print , doi: 10.1097/GME.0000000000002794.

    Managing Menopausal Symptoms: Common Questions and Answers.
    Chang JG, Lewis MN, Wertz MC. American Family Physician. 2023;108(1):28-39.

    Guest: Jillian Joseph, MPAS, PA-C
     
    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

    The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
  • Frankly Speaking About Family Medicine

    Leucovorin for Autism Spectrum Disorder: Is There Any Evidence Behind the Hype? - Frankly Speaking Ep 501

    2026/09/07 | 11 mins.
    Credits: 0.25 AMA PRA Category 1 Credit™
     
    CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-501

    Overview: Leucovorin has gained growing attention as a treatment for autism spectrum disorder (ASD), despite limited supporting evidence. In this episode, we discuss the rationale behind its use, review the current literature, and examine the American Academy of Pediatrics’ guidance on this treatment for ASD, giving you confidence to counsel families and engage in meaningful shared decision-making.

    Episode resource links:

    Discuss the rationale for using leucovorin in treatment of autism spectrum disorder (ASD)

    Review current evidence and practice guidelines regarding leucovorin and ASD

    Examine data and recent national trends in prescription rates of leucovorin for ASD

    Guest: Anne Powell, MD
     
    Music Credit: Matthew Bugos

    Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com 

    The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.
More Science podcasts
About Frankly Speaking About Family Medicine
A weekly Podcast series covering newsworthy topics in primary care medicine. Thoughts? Suggestions? Email us at FranklySpeaking@pri-med.com
Podcast website

Listen to Frankly Speaking About Family Medicine, Unexplainable and many other podcasts from around the world with the radio.net app

Get the free radio.net app

  • Stations and podcasts to bookmark
  • Stream via Wi-Fi or Bluetooth
  • Supports Carplay & Android Auto
  • Many other app features
Frankly Speaking About Family Medicine: Podcasts in Family